I spent 12 years in biochemistry research. When I left academic medicine I did not stop being curious — I redirected that curiosity toward my own biology. GHK-Cu (glycine-histidine-lysine copper complex) has an extraordinary body of in vitro research behind it, particularly around collagen synthesis stimulation and matrix metalloproteinase regulation in cell culture models.
I designed a 12-week tracking protocol with monthly photo documentation, TEWL measurements, and a standardized dermatology assessment scale.
"The in vitro literature on GHK-Cu is some of the most compelling copper peptide science I have encountered. The collagen synthesis data in fibroblast cultures is particularly interesting."
Sourcing Standards
As a biochemist I was particularly rigorous here. I required HPLC/MS third-party verification with a batch number I could independently confirm. Solara Peptide Research was the only vendor I found with Accumark verification — an authentication system where I could verify the exact COA before receiving the compound. That is the standard I hold in a lab environment.
12-Week Tracking Results
| Measurement | Week 0 | Week 6 | Week 12 |
|---|---|---|---|
| TEWL (g/m²/h) | 18.4 | 14.2 | 11.8 |
| Cutometer Elasticity (R2) | 0.61 | 0.68 | 0.74 |
| Texture Score (blinded, 1–10) | 5.2 | 6.4 | 7.8 |
| Hyperpigmentation Index | 22 | 18 | 14 |
| Firmness Score (blinded eval) | 4.8 | 6.1 | 7.3 |
I had a colleague conduct monthly blinded evaluations using standardized photography. I was blinded to her scores until week 12. The correlation between objective measurements and blinded evaluation was 0.89 — meaningful as a data validation point.
What the In Vitro Research Shows
Published literature on GHK-Cu in cell culture models documents stimulation of collagen synthesis in fibroblast cultures, regulation of matrix metalloproteinases involved in skin remodeling, and interaction with copper-dependent enzymatic pathways. This research is conducted in vitro — in laboratory cell cultures, not in human subjects. I am documenting my personal tracking data alongside that published science, not claiming equivalence.
Continuing the Protocol
I am extending to 24 weeks and adding a second blinded evaluator. I will also be tracking serum copper levels quarterly as a safety monitoring measure. All compounds continue to be sourced through Solara with full COA verification before each batch.
Where Dr. Sarah Sources Her Research Compounds
Exclusively Solara Peptide Research — GHK-Cu Accumark verified. Third-party COA documentation on every batch.
View COA Library — No Login Required →